Alborz Pharmed

Alborz Pharmed is a prominent Iranian pharmaceutical company specializing in the development, manufacturing, and distribution of a wide range of generic medicinal products. Established in 2001, the company operates as a key subsidiary of the Alborz Investment Group, which is part of the larger Barkat Pharmaceutical Group. Its product portfolio covers diverse therapeutic areas, including cardiovascular, central nervous system, gastrointestinal, and anti-infective treatments. Alborz Pharmed maintains modern manufacturing facilities compliant with international Good Manufacturing Practice (GMP) standards to supply the domestic Iranian market and regional exports. The company focuses on producing high-quality finished dosage forms, primarily in solid oral formats like tablets and capsules. By leveraging its position within a large industrial group, Alborz Pharmed plays a significant role in ensuring the availability of essential medicines in the Middle East. The company is committed to continuous improvement and expanding its portfolio to include more complex generic formulations.